SCHEMBL462710

SCHEMBL462710

Cc1nc2cc(-c3ccc4c(c3)CCCC4)nn2c(Cl)c1C(C)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
KDM4E B2RXH2 6/20 0.40
HTT P42858 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 7/20 0.38
RAB9A P51151 7/20 0.38
CASP3 P42574 1/20 0.38
ATM Q13315 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
NR1I2 O75469 1/20 0.36
PSIP1 O75475 2/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 6/20 0.35
HPGD P15428 5/20 0.35
LMNA P02545 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458714 0.90 KDM4E (0.40) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL462539 0.85 PSIP1 (0.51) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL461782 0.83 NPC1 (0.40) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL461275 0.83 NPC1 (0.40) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL461198 0.80 PSIP1 (0.42) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL461199 0.80 PSIP1 (0.42) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL461744 0.78 ALDH1A1 (0.40) ALDH1A1KDM4EHTTL3MBTL1MAPK1
SCHEMBL458941 0.77 NR1I2 (0.55) ALDH1A1KDM4EHTTL3MBTL1NPC1
SCHEMBL461811 0.77 NR1I2 (0.55) ALDH1A1KDM4EHTTL3MBTL1NPC1
SCHEMBL462711 0.77 MAPT (0.46) ALDH1A1KDM4EHTTL3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614064-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2013-07-17 EP disclosed
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed